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Title: Rurality of medical provider and race of patient as risk factors for overdose in opioid use
disorder populations
Background
This study examines the outcomes of medication assisted treatment (MAT) for opioid use
disorders (OUD) based on location of treatment and race of the individual seeking treatment.
Opioid use in the United States has been disproportionately rising in the last decade and there is
evidence of unequal treatment based on different social disparities, namely rurality and race.
Discriminatory distribution of medication and treatment for individuals seeking OUD along the
lines of race and rurality is an issue of grave importance in both medical and ethical fields.
Methods
Individuals seeking treatment for OUD were identified and the use of MAT and/or mental health
treatment (MHT) was analyzed. Data analysis of which course of treatment (MAT or MHT)
were protective factors against overdose were analyzed. MAT most commonly used to treat
OUD, buprenorphine, methadone, and naltrexone, were analyzed for risk of overdose following
treatment seeking for OUD. Using administrative Medicaid data, persons with a first episode
OUD diagnosis (N=9538) that were admitted to an emergency medical treatment facility in
2016-2018 and had no previous claims for OUD were identified using ICD 10 diagnostic codes.
The number that initiated medication within 30 days of diagnosis were identified, separated by
type of prescription: naltrexone=564, methadone=117, buprenorphine=2722, and no MAT=6187.
Demographic factors (age, race, zip code of housing, and gender) were obtained from patient
records, and pharmacy claims following OUD diagnosis were used to determine MAT group
(i.e., buprenorphine, naltrexone, methadone, or no MAT). Emergency department and hospital
claims were used to identify overdoses in the year following OUD diagnosis, and Cox regression
was used to analyze risk of overdose.
Proposed Hypothesis
We predict that being treated for OUD in rural areas or being of non-white race is a leading
factor of an individual recieving care that leads to overdose following treatment for being
diagnosed with OUD.

